OAKES BENJAMIN L. enters SCRIBE THERAPEUTICS, INC. with 506.60K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/24/2026ACC: 0002127814-26-000002
DirectorOfficerOther· President, CEO
Since Jul 2026
506.60K
Baseline shares
100% direct
506.60K
Direct ownership
1 position
175.08K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned506.60K
Total
506.60K direct506.60K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 506.60K | Direct |
| Total | 506.60K | 506.60K direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
25.33K
Shares owned
N/A
Exercise price
3.08
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
101.32K
Shares owned
N/A
Exercise price
6.40
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
35.46K
Shares owned
N/A
Exercise price
6.40
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
12.97K
Shares owned
N/A
Exercise price
19.13
Expiration
—
Exercise window
—
Total
Underlying
175.08K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 3.08 | — | — | 25.33K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 6.40 | — | — | 101.32K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 6.40 | — | — | 35.46K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 19.13 | — | — | 12.97K | N/A |
| Total | 175.08K | 0.00 | ||||